Ariel Precision Medicine, Inc. — Form D
Ariel Precision Medicine, Inc. of PITTSBURGH, PA, a company, filed a Form D exempt-offering notice with the SEC on 2019-07-08. The offering totals $8.8M, of which $5.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-07-08
- Form: D
- Accession: 0000898432-19-000986
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $8.8M
- Amount sold: $5.3M
- Remaining: $3.5M
- Investors: 20
- Date of first sale: 2019-06-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-343652
Issuer
- Name: Ariel Precision Medicine, Inc.
- CIK: 0001674590
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 5750 CENTRE AVENUE, PITTSBURGH, PA, 15206
- Phone: (412) 889-2849
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Jessica Gibson | Director | PITTSBURGH, PA |
| Christopher TB Moehle | Director | Pittsburgh, PA |
| Hank Safferstein | Director | Pittsburgh, PA |
| David TB Smith | Director | Pittsburgh, PA |
| David TB Whitcomb | Director | Pittsburgh, PA |
| Jessica Gibson | Executive Officer | PITTSBURGH, PA |
| John TB Moore | Executive Officer | PITTSBURGH, PA |
| David Smith | Director | Saint Louis, MO |
| John Moore | Executive Officer | Charlottesville, VA |
| Stephan Dietrich | Director | Cleveland, OH |
| David Whitcomb | Director | Pittsburgh, PA |
| Mary Del Brady | Director | Pittsburgh, PA |
| Mary Del Brady | Executive Officer | Pittsburgh, PA |
Other filings by this issuer (1)
More